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Vascular anomalies can be academically divided into two groups: vascular tumors and vas-
cular malformations. Among vascular malformations, we can highlight the arteriovenous
malformations, a subtype of anomaly characterized by presenting a high blood ﬂow. The
diagnosis is beyond doubt a great challenge for the multi professional team involved in
treating these anomalies. Imaging tests such as the ultrasonography, magnetic resonance,
CT  scan with contrast and angiography are extremely important for the orientation about
the  characteristics and hemodynamic properties of the blood vessels, for delivering pre-
dictable results and for risk reducing of complications. In this paper, we describe a rare case
of  extensive arteriovenous malformation in the face of a pediatric patient, its clinical char-
acteristics and imaging manifestations as well as the satisfactory clinical results obtained
with  a combination of sclerotherapy and surgical excision.
© 2014 Sociedade Portuguesa de Estomatologia e Medicina Dentária. Published by
Elsevier España, S.L.U. All rights reserved.
Extensa  malformac¸ão arteriovenosa  em  face  de  paciente  pediátrico–
Relato  de  caso
Palavras-chave:
Malformac¸ões vasculares
r  e  s  u  m  o
As anomalias vasculares podem ser didaticamente divididas em dois grupos: os tumores
vasculares e as malformac¸ões vasculares. Dentre as malformac¸ões vasculares, podemos
Face
Escleroterapia
destacar as malformac¸ões arteriovenosas, um subtipo de anomalia caracterizada por apre-
sentar um alto ﬂuxo sanguíneo. O diagnóstico é sem dúvida um grande desaﬁo para a equipe
multiproﬁssional envolvida no tratamento destas anomalias. Exames imaginológicos comoa  ultrassonograﬁa, ressonância magnética, tomograﬁa computadorizada com contraste
e  a angiograﬁa são fundamentais para orientac¸ão quanto as características e propriedades
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hemodinâmicas dos vasos sanguíneos, proporcionando resultados previsíveis e menor risco
de  complicac¸ões. Descrevemos um caso raro de extensa malformac¸ão arteriovenosa de face
em  paciente pediátrico, suas características clínicas e imaginológicas bem como os bons
resultados clínicos obtidos com a escleroterapia e exérese cirúrgica.
©  2014 Sociedade Portuguesa de Estomatologia e Medicina Dentária. Publicado por
Elsevier España, S.L.U. Todos os direitos reservados.
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Fntroduction
ascular anomalies are a set of changes of blood vessels that
ould be associated, or not, to endothelial cells proliferation
hat results in a vascular hamartomatous growth.1
There are many  discussions about the classiﬁcation of
hese anomalies and for this reason, the correct diagnosis is
mportant to establish the most appropriate therapeutic treat-
ent. Although most vascular abnormalities can be clinically
iagnosed, it is common knowledge that severe conditions
equire complementary tests for the differential diagnosis
etween soft tissue or bone neoplasms.
In 1996, the International Society for the Study of Vascu-
ar Anomalies (ISSVA) adopted and revised the classiﬁcation
ystem created by Mulliken & Glowacki in 1982,2 being con-
idered since then the ofﬁcial classiﬁcation system of vascular
nomalies. They proposed the division of these anomalies in
wo great groups: tumors (infantile hemangioma, congenital
emangioma, tufted angioma, kaposi hemangioendothe-
ioma) and malformations. The vascular malformations can
e subdivided into low-ﬂow (capillary, venous or lymphatic)
nd fast ﬂow malformations (arterial malformation and arte-
iovenous ﬁstula).3
Vascular malformations (VMs) are disorders of benign ori-
in, unusual to the maxillofacial region. They represent about
.4% of lesions found in the oral cavity. However, studies
n prevalence of these lesions are still scarce. The upper
nd lower lips along with the oral mucosa have the highest
ncidence.4
Although the VMs  in the head and neck region cause sig-
iﬁcant esthetic defects, nasal obstruction and interference
ig. 1 – Initial extraoral photography (facial deformity).on speech and dentition, the main concern of patients is the
possibility of severe and recurrent hemorrhages.5
Complementary methods such as computed tomography,
Doppler ultrasonography and magnetic resonance imaging,
in association with clinical ﬁndings can provide information
regarding blood ﬂow characteristics and lesions extent. Gen-
erally, low-ﬂow vascular malformations are percutaneously
treated with sclerosing agents injection, while in high ﬂow
lesions the approach is endovascular, with permanent liquid
or solid embolization agents.6
The aim of this rare case report of extensive arteriovenous
malformation in a pediatric patient’s face is to show the impor-
tance of a precise diagnosis obtained by imaging exams that
assisted the choice of treatment, proving an excellent long-
term clinical result.
Case  report
A female child, 9 years old, was referred to the oral and
maxillofacial surgery service at Baleia Hospital – Belo Hori-
zonte – Brazil, complaining of painless swelling in the chin
region. The mother reported that soon after the child’s
birth a small purplish spot appeared in the chin. Evolution
was slow, progressive and associated with recurrent bleed-
ing episodes, sometimes spontaneous. Facial asymmetry and
concern about the possibility of bleeding limited the patient’s
social life and practice of physical activity.
The extra oral clinical examination showed an increased
volume of ﬁrm consistency, with well-deﬁned margins and
blue-purplish coloration on mental region. Blood vessels
superﬁcialization was clinically suggested (Fig. 1). It was pos-
sible to observe, during intraoral clinical examination, that
the lesion extended to the right side of the rear region of the
mouth. The anterior lower teeth were crowded and lingualized
(Fig. 2).
The intravascular puncture aspiration by an intrabuccal
access, revealed the presence of pulsatile blood content.
Initially, an ultrasonography was requested to evaluate the
characteristics of the soft tissue volume, the distribution of
vascular structures and the intensity of blood ﬂow present in
the lesion. The ultrasound examination showed an intense
arteriovenous ﬂow suggesting the hypothesis of hemangioma.
There was a suspicion of bone tissue involvement due to
dental misalignment. Then, we decided not to use resonance
imaging exam due to its limitation in analyzing the hard tis-
sues, if compared to the beneﬁts of CT scan with contrast. The
CT scan identiﬁed a small calciﬁcation in the soft tissue, with
no bone continuity circumscribed by an intense vasculariza-
tion area suggesting a phlebolith (Fig. 3).
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Fig. 4 – Extraoral photography after a 3-year follow-upFig. 2 – Initial photography (intraoral dental malposition).
After local anesthesia (2% mepivacaine hydrochlroride
with 1:20.000 corbadrine, DFL®, Rio de Janeiro, Brazil) an intra
vascular 1 cc ethanolamine oleate diluted in 4 cc of distilled
water was injected, in the extra-oral lesion, and another 1 cc
of the solution with the same concentration was injected in
the intraoral region. The same regimen was repeated at regu-
lar intervals of 7 days. This drug, when injected into the vessel
produces a dose-dependent inﬂammatory response, resulting
in vessel wall ﬁbrosis with possible occlusion of the same.
During the seven weeks we  observed a continuous lesion
regression. After six sessions a signiﬁcant decrease of the
lesion was observed and, the aspiration of blood content was
negative, suggesting ﬁbrosis of the lesion.
Nimesulide were administered at a dosage of 100 mg  of
12 in 12 h, for three days, after each application aiming the
reduction of the swelling and the healing time of the area that
received the injection.Phlebolith and ﬁbrosis were surgically removed with no
major bleeding. The surgical procedure was performed under
local anesthesia, using an intraoral access to the chin. The
Fig. 3 – Initial CT scan with contrast (vascularization
and phlebolith).period (correction of facial deformity).
patient was treated with Nimesulide at a dosage of 100 mg,
twice daily, during three days. We recommended icepack on
chin region in the ﬁrst 72 h and maintenance of extra-oral
pressure dressing for two days to prevent swelling.
After a 3-year follow-up period, facial asymmetry was sig-
niﬁcantly decreased, there was no episode of spontaneous
bleeding or disturbance of teeth alignment (Figs. 4 and 5).
A new CT scan (Fig. 6) showed less local vascularity as well
as decreased calciﬁcation dimensions.
Discussion  and  conclusion
The history of vascular anomalies presents classiﬁcations that
include overlap of terms. This diagnostic complexity can pro-
duce sequels to patients because of misguided choices of
treatment. Vascular tumors present distinctive clinical char-
acteristics that are generally the contrary to malformations.
VMs are present since birth and never disappear; in addition,
Fig. 5 – Intraoral photography after a 3-year follow-up
period (natural alignment of teeth).
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Fig. 6 – CT scan with contrast after the last session of
sclerotherapy (involution of vascularization and phlebolith).
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signs and symptoms due to vascular lesion substitution by
a ﬁbrosis tissue. Ethanolamine oleate dose and frequencyhey may increase in size over the years as it was in this case
eport.7
VMs  may be associated with the development of the skele-
on, presenting extra or intra osseous location, and cause
ome bone changes. In this case, the extra osseous lesion did
ot cause changes in the size or density of the jaw. However,
e  observed a change in the contour of the alveolar ridge
aused by the expansion of soft tissue injury. Although VMs
ay involve an extensive facial deformity, the hazard is a pos-
ible abundant and often, uncontrollable bleeding, mainly in
rterial malformations.8 They can be classiﬁed as high or low
lood ﬂow. The former are relatively uncommon. Although
hey generally happen randomly, they may have a familial
haracteristic and be genetically determined.9
The nature of vascular channels, capillary, arterial, venous
r lymphatic, may also be categorized vascular malforma-
ions. It is common the coexistence of many  vessels types
n the same lesion.10 This situation has been observed in the
linical case presented, conﬁrmed by the ultrasound exam.
The proper diagnosis of these malformations should be ini-
iated from an early history interview and a detailed clinical
xamination of the lesion. Imaging exams such as ultrasound,
RI, CT scan with contrast and angiography are crucial.11
The ultrasonography presents advantages such as low
ost, easy availability and it spares the patient’s exposure
o ionizing radiation. However, some limitations should be
ighlighted such as low resolution of the image  that limits
ccurate identiﬁcation of the lesion, especially in depth. Fur-
hermore, with this exam is difﬁcult to identify possible bone
nvolvement.12
Magnetic resonance imaging exam has been used exten-
ively for precise lesion delimitation and adjacent soft tissue
ssociation.7 Magnetic resonance imaging is effective both in
iscovering and as well monitoring vascular anomalies and
an be considered a non-invasive method.13
Computed tomography and magnetic resonance imaging
re recognized standard tools in oral and maxillofacial surgical
ractice. However, the CT scan with contrast is able to identify a x i l o f a c . 2 0 1 4;5  5(4):250–255 253
bone disorders such as the presence of phleboliths, calciﬁca-
tions arising of the inﬂammatory processes in the veins.14
Angiography in turn, has limited indication. It is used
generally to investigate the origin of blood supply and
the dynamics of arteriovenous ﬂow, especially in cases of
endovascular interventions.12
Histopathological exam was not used for surgical planning
given that deﬁnitive diagnosis is clinical, through imaging
investigation. However, histology can contribute to conﬁrm
the nature of the vascular channels.7 We emphasize that the
procedure of biopsy may expose the patient to surgical risks
with blood loss.
After reaching a consensus on a deﬁnitive diagnosis, the
participation of a multi professional team was fundamental
for the establishment of the best suited therapeutic treat-
ment. If the choice is surgical therapy, attention to the size
and shape of the lesion should be given. Surgery is more  suit-
able in cases where the lesion is well deﬁned and far from
important anatomical structures.15
The age of the patient, the degree of partaken with sur-
rounding tissue and the characteristics of that lesion, had
led to a more  conservative initial treatment. The non-surgical
treatment is reported in the use of systemic corticosteroids,
interferon-alpha, low intensity laser therapy, radiotherapy,
sclerotherapy and trans arterial embolization, complemented
or not by surgical treatment. Sclerotherapy associated to
surgical treatment has been the most common treatment
described.7,16–19
Sclerosing solutions can be divided into three cate-
gories: detergents, osmotic and chemical (composed).16 In the
case reported monoethanolamine oleate was used because
it is considered safe and with a low rate of complica-
tions. This drug, when injected into the vessel produces
a dose-dependent inﬂammatory response, resulting in ves-
sel wall ﬁbrosis with possible occlusion of the same.
The sclerosing agent spreads through the vessel wall and
causes an extra vascular inﬂammatory and a reactional
ﬁbrosis.21
Ethanolamine oleate sclerosing agent is composed of 4.23%
weight/volume of oleic acid, 0.910% weight/volume of ethamo-
line and excipients, namely benzyl alcohol and water for
injection. Each ampoule has a volume of 2 cc, with indi-
vidual dosage in vials of 0.5–2 cc; which must not exceed
6 cc. Its administration should be carried out slowly, avoid-
ing touching the perivascular region, as it may result in
ulceration or even tissue necrosis.22 Ethanolamine oleate
is contraindicated in patients with hypersensitivity to any
component of the formula, as well as in the following cir-
cumstances: varicose veins, voluminous, ostial and valvular
insufﬁciency; cutaneous lesion in the skin to be treated;
acute infections; serious systemic diseases; arterial occlusive
diseases; deep vein thrombosis; senile or non cooperative
patients; pregnant women in the 1st and 3rd trimester
or in lactation; stasis ulcer; acute phlebitis and severe
edema.21
Literature presents many  cases of complete resolution ofof injections depended on the site and dimension of the
lesion.20,22–24 Another case reports involving the region of
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face and great extension were not found in the literature.
The maximum dose that has been reported is 0.4 ml/kg
and fraction injections varying between 0.5 and 10 cc per
session.24
Different concentrations, between 1.5% and 2.5%, have
reported equal clinical results around 95% of lesions regres-
sion. Therefore it is preferable to use the lower concentration
(1.25%) to prevent complications such as kidney damage,
reduction of ﬁbrosis, pain, redness and heat.22,24 In the case
reported, we injected the sclerosing agent at 2.5% based on the
lesion dimensions at its aggressive appearance. In addition,
no complications were either observed in the perioperative or
postoperative period.
Despite patients’ present pain and edema after injections,
they vary in intensity and usually last a short period. Gener-
ally it is a safe procedure and well tolerated by patients.23 In
the case described on this paper, the patient had no compli-
cations at any time, which allowed us to give the same dose
that was chosen with the hematology team and also made us
conﬁdent about choosing the frequency of applications found
in the literature.
Finally, most of the studies on vascular anomalies are ret-
rospective studies. Prospective long term investigations are
needed to demonstrate the non-recurrence of these lesions.
More  speciﬁc information about preparation of ethanolamine
oleate solution and standardization of the doses applied in
each session are lacking.
The participation of a multidisciplinary team and the
request a ultrasound exams and the CT scan with contrast
allowed proper diagnosis and the correct choice of treatment
plan in two stages. The dosage used and the interval between
the applications of the sclerosing solutions have allowed the
necessary ﬁbrosis of the lesion, without any complication after
the injections and/or during the soft tissue-plasty and removal
of the phlebolith, therefore, it is an effective method for the
treatment of extensive arteriovenous malformations in the
face.
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